Navigation Links
Orexigen(R) Therapeutics Announces Second Quarter 2009 Financial Results
Date:8/6/2009

SAN DIEGO, Aug. 6 /PRNewswire-FirstCall/ -- Orexigen(R) Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, today announced unaudited financial results for the three months ended June 30, 2009.

Three Months Ended June 30, 2009

As of June 30, 2009, Orexigen held $8.6 million in cash and cash equivalents and an additional $37.4 million in investment securities, available-for-sale. In July 2009, Orexigen completed a public offering, the estimated net proceeds of which totaled $81.6 million. The pro forma balance of cash, cash equivalents and investments, available-for-sale, including the estimated net proceeds of the public offering, is $127.6 million.

For the three months ended June 30, 2009, Orexigen reported a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, as compared to a net loss of $23.1 million, or $0.67 per share attributable to common stockholders, for the comparable period in 2008.

Total operating expenses for the three months ended June 30, 2009 were $17.6 million compared to $23.7 million for the comparable period in 2008. The decreased operating expenses were due primarily to a decrease of $6.3 million in research and development expenses in connection with the completion of the Company's Contrave(R) Phase 3 clinical trials, reduced product formulation work and consulting activities, partially offset by an increase in licensing costs, New Drug Application preparation costs, salaries and personnel related costs. In addition, general and administrative expenses increased approximately $200,000 due primarily to an increase in salaries and personnel related costs.

"The recent completion of the COR Phase 3 program was a major milestone for Orexi
'/>"/>

SOURCE Orexigen Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Orexigen(R) Therapeutics Prices Public Offering of Common Stock
2. Orexigen(R) Therapeutics Announces Proposed Public Offering of Common Stock
3. Orexigen(R) Therapeutics Announces In-Licensing of Key Patents to Further Strengthen its Intellectual Property Estate for Contrave(R)
4. Orexigen(R) Therapeutics Names Michael Narachi, 24-Year Biopharmaceutical Veteran, New President and Chief Executive Officer
5. Orexigen(R) Therapeutics Names Patrick Mahaffy to Board of Directors
6. Orexigen(R) Therapeutics to Speak at J.P. Morgan Healthcare Conference
7. Orexigen(R) Therapeutics Announces Webcast of Third Quarter Financial Results on November 6, 2008
8. Cell Therapeutics, Inc. (CTI) to Report Second Quarter Financial Results on August 6
9. Quark Pharmaceuticals to Participate in IBCs Oligonucleotide Therapeutics: From Concept to Implementation Conference
10. United Therapeutics Corporation Reports Second Quarter 2009 Financial Results
11. Cell Therapeutics Initiates Process to Obtain Marketing Approval for Pixantrone in Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... 19, 2013 The website HealthNewsWires.com has ... resistance, its harmful effects and tips to manage and ... video from HealthNewsWires.com, the author defines insulin resistance ... efficiently remove and process glucose from the bloodstream. ... by all cells, organs and systems of the body ...
(Date:6/19/2013)... Audibel Hearing Center is pleased ... patients, the A2 with Multiflex Tinnitus Technology. Tinnitus ... in the ears. Although bothersome, tinnitus usually isn’t ... , Using their patent-pending Multiflex Tinnitus Technology, the ... sound stimulus that resonates through the patient’s ear. ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 As Mirena ... LLP highlights a recent news story from an NBC ... effects of the hormone-based contraceptive device. The Rottenstein Law ... to file Mirena lawsuits and who are ... The U.S. Food and Drug Administration has logged more ...
(Date:6/19/2013)... Anant Goel, CEO at RKNet Studios ... industrial revolution began in Britain in the late 18th century, ... was born. The second industrial revolution came in the early ... and ushered in the age of mass production. Now a ... is going digital and this could change not just business, ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 On 31 ... the concern about involuntarily detaining patients, a proposal put ... holistic addiction and mental health service provider , The ... apprehension about the suggestion. The centre’s Director and ... assumes those suffering from mental health issues have no ...
Breaking Medicine News(10 mins):Health News:Effects of Insulin Resistance and How to Increase Insulin Sensitivity Published in New Video by Health News Wire 2Health News:Audibel Hearing Center Introduces A2 with Multiflex Tinnitus Technology 2Health News:Rottenstein Law Group LLP Comments on News Reports of Mirena IUD Side Effects 2Health News:RKNet Studios Announced Cognitions Bridge Intelligence Games for Fun, Cognitive Skills Testing and Development for Success in Life 2Health News:RKNet Studios Announced Cognitions Bridge Intelligence Games for Fun, Cognitive Skills Testing and Development for Success in Life 3Health News:RKNet Studios Announced Cognitions Bridge Intelligence Games for Fun, Cognitive Skills Testing and Development for Success in Life 4Health News:Involuntary Detention Proposal Dehumanizing, Says Holistic Mental Health Service Provider The Australian Addiction And Trauma Treatment Centre 2Health News:Involuntary Detention Proposal Dehumanizing, Says Holistic Mental Health Service Provider The Australian Addiction And Trauma Treatment Centre 3
... ... tomography examinations underscore the important role that competent, educated CT technologists play in ... , ... Albuquerque, NM (Vocus) December 16, 2009 -- Two recent studies examining radiation doses ...
... , VIRGINIA BEACH, Va., Dec. 17, ... 12 Hampton Roads-area non-profit organizations at its first ,Breakfast ... mistress of ceremonies was local television personality, Barbara Ciara, ... breakfast keynote speaker was world-renowned ,champion, and four-time heavyweight ...
... Dec. 17 Motionsoft, Inc. announced today that it has ... Standards (DSS) certification, making it one of only a handful ... has been granted PCI compliance. , The PCI Standard is ... major credit card companies (Visa International, MasterCard Worldwide, American Express, ...
... , MIAMI, Dec. 17 ... , today announced that it has issued its financial ... financials are being posted today on the Pink Sheets (www.pinksheets.com). ... , Physicians Healthcare Management Group, Inc. (Phyhealth) is ...
... ... Inc. (OTC Bulletin Board: VHGI) confirmed today that VHGI Gold ... for a key advisory board position to assist with evaluating ... a decision for the role and hopes to make an ...
... and glutathione S-transferase T1 (GSTT1) null genotypes have been ... regarding the association between GSTM1 and GSTT1 null genotypes ... However, the majority of previous reports are limited by ... GSTM1/GSTT1 null genotype with the risk of GC and ...
Cached Medicine News:Health News:ASRT Supports Efforts to Minimize CT Radiation Dose 2Health News:ASRT Supports Efforts to Minimize CT Radiation Dose 3Health News:ASRT Supports Efforts to Minimize CT Radiation Dose 4Health News:The Amerigroup Foundation 'Breakfast of Champions' Honors Community Leaders with Boxing Champion Evander Holyfield 2Health News:The Amerigroup Foundation 'Breakfast of Champions' Honors Community Leaders with Boxing Champion Evander Holyfield 3Health News:Motionsoft Completes PCI Compliance Certification 2Health News:Phyhealth Issues September 30, 2009 Financial Statements 2Health News:VHGI: VHGI Gold Targets Candidates to Fill Key Advisory Board Position to Evaluate International Mining Acquisitions; Internet Town Hall Meeting Details Emerge, Kitco Gold Coverage Initiated 2Health News:VHGI: VHGI Gold Targets Candidates to Fill Key Advisory Board Position to Evaluate International Mining Acquisitions; Internet Town Hall Meeting Details Emerge, Kitco Gold Coverage Initiated 3Health News:VHGI: VHGI Gold Targets Candidates to Fill Key Advisory Board Position to Evaluate International Mining Acquisitions; Internet Town Hall Meeting Details Emerge, Kitco Gold Coverage Initiated 4
(Date:6/18/2013)...   Polymer Technology Systems, Inc. (PTS) ... to integrate the CardioChek ® PA ... health systems across the country. The CardioChek PA ... through Hanson Medical Systems , offers immediate, ... cholesterol, triglycerides, and glucose. (Logo: ...
(Date:6/17/2013)... Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: ... ENDO 2013, the Endocrine Society,s 95 th ... both melatonin and cortisol rhythms. This effect further ... clock and address the circadian desynchrony which is ... and Efficacy of Tasimelteon) and RESET (Randomized-withdrawal study ...
(Date:6/17/2013)... , June 17, 2013 DNAtrix Inc., experts ... will present clinical data on the company,s lead product, ... Quebec City, Canada on June ... DNAtrix,s CEO and a leader in the field of ... study entitled A PHASE I TRIAL OF A CONDITIONALLY ...
Breaking Medicine Technology:Polymer Technology Systems, Inc. to Provide Point-of-Care Lipid Testing to Aegis Health Group's Hospital Clients 2Polymer Technology Systems, Inc. to Provide Point-of-Care Lipid Testing to Aegis Health Group's Hospital Clients 3Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 2Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 3Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 4DNAtrix, Inc. to Present Clinical Study Results for DNX-2401 (Delta 24-RGD), A Conditionally Replication-Competent Adenovirus 2
... Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ), the ... a company overview at J.P. Morgan,s 29th Annual Healthcare Conference ... the Westin St. Francis Hotel in San Francisco, CA. ... be available on the "Investors & Media" section of the ...
... Mass., Jan. 6, 2011 Saints Medical Center, a ... is pleased to announce it has entered into a ... ZOLL ) of Chelmsford, Mass., a leader in comprehensive ... Saints-based EMS service working with ZOLL to collaborate on ...
Cached Medicine Technology:Isis Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference 2Saints Medical Center and ZOLL Medical Corporation Enter Collaborative Agreement 2Saints Medical Center and ZOLL Medical Corporation Enter Collaborative Agreement 3
... contains primers and a FAM-labeled probe that ... (RSV). In addition, this ASR contains primers ... sample processing control. This ASR requires an ... Red reporter dyes such as the Cepheid ...
... contains primers and a FAM-labeled probe that is ... the Staphylococcus protein A gene. In addition, this ... DNA for an internal control sequence. This ASR ... Texas Red reporter dyes such as the Cepheid ...
Clot-based Assay for Anti-FXa and/or Anti-Iia Therapies...
Reptilase-Time from Bothrops atrox...
Medicine Products: